Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Pulse Biosciences (PLSE) Operating Expenses (2021 - 2025)

Historic Operating Expenses for Pulse Biosciences (PLSE) over the last 5 years, with Q3 2025 value amounting to $20.5 million.

  • Pulse Biosciences' Operating Expenses rose 4978.4% to $20.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $79.0 million, marking a year-over-year increase of 6285.73%. This contributed to the annual value of $56.3 million for FY2024, which is 2910.68% up from last year.
  • Per Pulse Biosciences' latest filing, its Operating Expenses stood at $20.5 million for Q3 2025, which was up 4978.4% from $20.3 million recorded in Q2 2025.
  • Pulse Biosciences' 5-year Operating Expenses high stood at $20.5 million for Q3 2025, and its period low was $8.7 million during Q4 2022.
  • Over the past 5 years, Pulse Biosciences' median Operating Expenses value was $14.8 million (recorded in 2021), while the average stood at $14.8 million.
  • As far as peak fluctuations go, Pulse Biosciences' Operating Expenses crashed by 4625.32% in 2022, and later skyrocketed by 7290.64% in 2025.
  • Quarter analysis of 5 years shows Pulse Biosciences' Operating Expenses stood at $16.3 million in 2021, then tumbled by 46.25% to $8.7 million in 2022, then surged by 43.46% to $12.5 million in 2023, then soared by 61.66% to $20.3 million in 2024, then grew by 0.95% to $20.5 million in 2025.
  • Its last three reported values are $20.5 million in Q3 2025, $20.3 million for Q2 2025, and $18.0 million during Q1 2025.